FDAnews
www.fdanews.com/articles/84756-mayne-on-the-prowl-despite-66m-loss

MAYNE ON THE PROWL DESPITE $66M LOSS

February 22, 2006

Pharmaceuticals manufacturer Mayne Pharma said yesterday that it was on the acquisition trail and considering the possibility of selling shares on the London Stock Exchange. Mayne Pharma said the moves were part of a strategic review to be presented to the board next month.

The Australian (http://www.theaustralian.news.com.au/common/story_page/0,5744,18241014%255E643,00.html)